Filing Details

Accession Number:
0001140361-16-089899
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-15 20:48:23
Reporting Period:
2016-12-13
Filing Date:
2016-12-15
Accepted Time:
2016-12-15 20:48:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS Pharmaceutical Preparations (2834) 141902018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1380177 Ronald Richard 400 Professional Dr, Suite 400
Gaithersburg MD 20879
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-01 152 $0.00 19,870 No 4 J Direct
Common Stock Acquisiton 2016-08-01 604 $0.00 20,474 No 4 J Direct
Common Stock Acquisiton 2016-08-01 577 $0.00 21,051 No 4 J Direct
Common Stock Disposition 2016-12-13 5,800 $34.09 15,251 No 4 S Direct
Common Stock Disposition 2016-12-13 100 $34.06 15,151 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Direct
No 4 J Direct
No 4 J Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. In connection with the spin-off (the "Spin-off") of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc. ("Emergent"), on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the Spin-off. The restricted stock units vest in May 2017.
  2. In connection with the spin-off (the "Spin-off") of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc. ("Emergent"), on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the Spin-off. The restricted stock units vest in May 2017 and May 2018.
  3. In connection with the spin-off (the "Spin-off") of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc. ("Emergent"), on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the Spin-off. The restricted stock units vest in May 2017, May 2018 and May 2019.